COMMUNIQUÉS West-GlobeNewswire

Amedisys to Repurchase 50% of Shares Held by KKR

04/06/2018 - 22:30

Accretive Transaction to Reduce Outstanding Shares by 2.4 Million or 7.1% KKR to Maintain its Board Seat For at Least Twelve Months Following the Transaction BATON ROUGE, La., June 04, 2018 (GLOBE NEWSWIRE) -- Amedisys [...]

Portola Pharmaceuticals Announces Retirement of CEO Bill Lis in 2018

04/06/2018 - 22:30

SOUTH SAN FRANCISCO, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq:PTLA) today announced that William Lis has informed the Board of Directors of his plans to retire as Chief Executive [...]

INSYS Therapeutics to Present at Jefferies Global Healthcare Conference

04/06/2018 - 22:15

PHOENIX, June 04, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, announced today that [...]

HealthEquity Reports First Quarter Ended April 30, 2018 Financial Results

04/06/2018 - 22:07

Highlights of the first quarter include: Revenue of $69.9 million, an increase of 26% compared to Q1 FY18. Net income of $22.6 million, an increase of 61% compared to Q1 FY18. Net income per diluted share of $0.36 [...]

Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference 2018

04/06/2018 - 22:05

RANCHO CUCAMONGA, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, will be presenting at the Jefferies Healthcare Conference on Tuesday, June [...]

Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

04/06/2018 - 22:05

WAYNE, Pa., June 04, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative and differentiated [...]

Opiant Pharmaceuticals to Participate in Opioid Panel at the BIO International Convention

04/06/2018 - 22:05

Roger Crystal, M.D., Chief Executive Officer, will be a Panelist on “Biology of Pain and Addiction - Next Generation Treatments for Pain and Addiction,” and Present a Corporate Overview SANTA MONICA, Calif., June 04, [...]

Ultragenyx to Present at Upcoming Investor Conferences

04/06/2018 - 22:05

NOVATO, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, will present at [...]

Align Technology Global Funding Awarded Towards Advancing Orthodontic and Dental Research

04/06/2018 - 22:02

$300,000 in Research Grants Awarded as Part of its Ongoing Annual Research Awards Program SAN JOSE, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq:ALGN) today announced eleven recipients of [...]

Collegium Announces CEO Succession

04/06/2018 - 22:01

Joseph Ciaffoni Promoted to CEO and Appointed to Board Michael Heffernan Continues to serve as Chairman of the Board CANTON, Mass., June 04, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (NASDAQ:COLL) today [...]

Sientra to Present at the William Blair 38th Annual Growth Stock Conference

04/06/2018 - 22:01

SANTA BARBARA, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, announced today that Jeff Nugent, President and Chief Executive Officer, and Patrick F. Williams, Chief [...]

PolarityTE Announces Public Offering of Common Stock

04/06/2018 - 22:01

SALT LAKE CITY, June 04, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, [...]

HEALTH FOUNDATION OF SOUTH FLORIDA ELECTS DIONNE E. WONG TO BOARD OF DIRECTORS

04/06/2018 - 21:07

MIAMI,FL-, June 04, 2018 (GLOBE NEWSWIRE) -- Health Foundation of South Florida announced the election of Dionne E. Wong to its Board of Directors. The board leads the largest philanthropy dedicated to improving health [...]

The Association of Ontario Health Centres is Now Alliance for Healthier Communities

04/06/2018 - 20:50

TORONTO, June 04, 2018 (GLOBE NEWSWIRE) -- Ontario’s voice for community-governed comprehensive primary health care has a new name, and it’s official as of today: Alliance for Healthier Communities . Members of the [...]

L'Association des centres de santé de l’Ontario devient l’Alliance pour des communautés en santé

04/06/2018 - 20:50

TORONTO, 04 juin 2018 (GLOBE NEWSWIRE) -- La voix de l’Ontario pour les soins primaires complets et régis par la communauté porte un nouveau nom, et c’est officiel à compter d’aujourd’hui : l’ Alliance pour des [...]

Rafael Pharmaceuticals to Present at 2018 BIO International Convention

04/06/2018 - 20:33

Rafael was nominated in the Pipelines of Promise category this year Newark, NJ, June 04, 2018 (GLOBE NEWSWIRE) -- Sanjeev Luther, President & CEO of Rafael Pharmaceuticals, Inc., will present the company’s clinical [...]

Sanofi: New England Journal of Medicine publishes pivotal cemiplimab trials showing positive results in advanced cutaneous squamous cell carcinoma

04/06/2018 - 20:16

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) New England Journal of Medicine publishes pivotal cemiplimab trials showing positive results in advanced cutaneous squamous cell carcinoma Patients treated with [...]

Sanofi : Le New England Journal of Medicine publie les résultats positifs d'essais cliniques pivots du cemiplimab dans le traitement de carcinome épidermoïde cutané au stade avancé

04/06/2018 - 20:16

Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) Le New England Journal of Medicine publie les résultats positifs d'essais cliniques pivots du cemiplimab dans le traitement de carcinome épidermoïde [...]

Dynavax Reports Data for Phase 1b/2 Trial of SD-101 in Combination with KEYTRUDA® (pembrolizumab) in Advanced Melanoma at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

04/06/2018 - 20:15

Overall Response Rate (ORR) of 70% and 6-month Progression Free Survival (PFS) rate of 76% in Patients Naïve to Anti-PD-1 Treatment who Received the ≤ 2mg Dose of SD -101 Combination showed Similar Rates of Immune- [...]